Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/13/2015 04/14/2015 04/15/2015 04/16/2015 04/17/2015 Date
127.81(c) 128.73(c) 129.2(c) 128.94(c) 125.07(c) Last
1 004 832 949 006 1 203 780 1 142 328 1 579 115 Volume
-0.51% +0.72% +0.37% -0.20% -3.00% Change
More quotes
Financials ($)
Sales 2015 1 076 M
EBIT 2015 -296 M
Net income 2015 -429 M
Finance 2015 584 M
Yield 2015 -
Sales 2016 2 894 M
EBIT 2016 1 230 M
Net income 2016 1 000 M
Finance 2016 1 414 M
Yield 2016 -
PER 2015 -
PER 2016 35,63
EV / Sales 2015 28,5x
EV / Sales 2016 10,3x
Capitalization 31 215 M
More Financials
Company
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets.It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious... 
Sector
Pharmaceuticals
Calendar
04/29Earnings Release
More about the company
Surperformance© ratings of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on VERTEX PHARMACEUTICALS INC
04/16 VERTEX PHARMACEUTICALS : Data on Influenza Discussed by Researchers at Vertex Ph..
04/16 VERTEX PHARMACEUTICALS : Patent Issued for Method for Measuring ATR Inhibition M..
04/15 VERTEX PHARMACEUTICALS : to Announce First Quarter 2015 Financial Results on Apr..
04/15 NASDAQ 100 MOVERS : Vrtx, wdc
04/13 VERTEX PHARMACEUTICALS : Health and Human Services Department (HHS); Food and Dr..
04/09 VERTEX PHARMACEUTICALS : to Announce First Quarter 2015 Financial Results on Apr..
04/08 VERTEX PHARMACEUTICALS : New Ulcerative Colitis Study Findings Reported from Ver..
04/08 VERTEX PHARMACEUTICALS : Researchers from Vertex Pharmaceuticals Inc. Report New..
More news
Sector news : Biopharmaceuticals
11:03p TEVA PHARMACEUTICAL : BRIEF: Mylan says it is not interested in merger with Isra..
08:16p TEVA PHARMACEUTICAL : Mylan discounts speculation of a possible takeover by Teva
05:54p VALEANT PHARMACEUTICALS INTL : senior executives scored US$123 million compensat..
More sector news : Biopharmaceuticals
News from SeekingAlpha
04/09 WHY INVESTORS SHOULDN'T WORRY ABOUT : Maxim's Jason Kolbert
04/08 Among The Jitters, Big Pharma Laggards Make Up Lost Ground
03/23 2015 could be the year of the blockbuster drug
03/23 Vertex Pharma off on trial data for VX-661
03/18 FDA clears Vertex CF drug for use in younger children


Comments 
Advertisement
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF